News - Pharmaceuticals
PCFA condemns funding axe and demands Prime Minister intervene
The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]
MoreNews - MedTech & Diagnostics
Australia has a new genomics framework. But will patients see the difference?
The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]
MoreNews - Biotechnology
TGA grants licence to Australia’s first viral vector manufacturing facility
The Therapeutic Goods Administration (TGA) has granted Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector contract development and manufacturing […]
MoreDigital & Innovation
Health sector faces new privacy obligations
Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]
MoreLeadership & Management
Astellas Australia appoints Guillaume Pfeiffer as GM
Astellas has appointed Guillaume Pfeiffer as General Manager of Australia, with the pharmaceutical company’s new country leader set to take […]
MoreESG
Healthcare sustainability policies enter ‘uncharted territory’
Sustainability is no longer a future conversation for healthcare. It is a policy, procurement and manufacturing reality. In this Health […]
MoreHuman Resources
Merck puts the ‘family’ in workplace as fertility survey exposes gaps
Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]
MoreMedical and Science
‘Kidney in a dish’ pioneer wins Research Australia’s top honour
Six researchers and institutions have been recognised at Research Australia’s 22nd Health and Medical Research Awards, with Professor Melissa Little […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
Merck puts the ‘family’ in workplace as fertility survey exposes gaps
September 16, 2026
in Human Resources
Australia has a new genomics framework. But will patients see the difference?
September 16, 2026
in News - MedTech & Diagnostics
PCFA condemns funding axe and demands Prime Minister intervene
September 16, 2026
in News - Pharmaceuticals
Sanofi’s clinical-trial push hits a GP reality check
September 16, 2026
in News - Pharmaceuticals
New funding to bring global CAR-T trials to young cancer patients
September 14, 2026
in News - Pharmaceuticals
Rising gynae cancers meets a system forcing patients to pay the price
September 14, 2026
in News - Pharmaceuticals
Analysis confirms private health insurance cuts target vulnerable pensioners
September 14, 2026
in News - MedTech & Diagnostics
Chalmers retreats as startup tax backlash forces further changes
September 14, 2026
in News - MedTech & Diagnostics
MSAC backs funding of genomic testing in endometrial cancer
September 14, 2026
in News - MedTech & Diagnostics
Health sector faces new privacy obligations
September 11, 2026
in Digital & Innovation
TGA approves new antibiotic but AMR blind spot remains a critical concern
September 11, 2026
in News - Pharmaceuticals
BCAL Diagnostics rejects merger speculation
September 11, 2026
in News - MedTech & Diagnostics
Australia backs infectious disease innovation as US funding faces more cuts
September 11, 2026
in News - Pharmaceuticals
GenesisCare debuts first next-gen radiosurgery platform in Australia
September 10, 2026
in News - MedTech & Diagnostics
TGA grants licence to Australia’s first viral vector manufacturing facility
September 10, 2026
in News - Biotechnology
Rare cancers, submarines and the price of the messy middle
September 10, 2026
in News - Pharmaceuticals
The ‘rare’ case for a reform agenda that changes the reflection
September 8, 2026
in News - Pharmaceuticals
New petition takes aim at cutting the cost of cancer care
September 8, 2026
in News - Pharmaceuticals
National Lobbying Act to clean up politics
September 8, 2026
in News - MedTech & Diagnostics
Follow Us
Partner with us
Human Resources
Merck puts the ‘family’ in workplace as fertility survey exposes gaps
Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]
MoreNews - MedTech & Diagnostics
Australia has a new genomics framework. But will patients see the difference?
The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]
MoreNews - Pharmaceuticals
PCFA condemns funding axe and demands Prime Minister intervene
The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]
MoreNews - Pharmaceuticals
Sanofi’s clinical-trial push hits a GP reality check
New research from Sanofi presented at the Australian Public Health Conference this week points to an addressable opportunity to increase […]
More